GKB Ophthalmics has informed that pursuant to Regulation 25 (3 and 4) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and schedule IV, clause VII of the Companies Act 2013, a separate meeting of the Independent Directors of the Company, will be held on Monday, March 23, 2020, at the Registered Office of the Company, to review the performance of the Non-Independent Directors and the Board as a whole; to review the performance of the Chairman of the Company; to assess the quality, quantity and timeliness of flow of information between the Company Management and the Board that is necessary for the Board to effectively and reasonably perform their duties; and any other matter with the permission of the Chair.
The above information is a part of company’s filings submitted to BSE.
